CLAS

Dr. Rachel Hardeman, Renowned Reproductive Health Equity Researcher, Joins Maven Clinic as Visiting Scientist

Retrieved on: 
Wednesday, March 27, 2024

NEW YORK, March 27, 2024 /PRNewswire/ -- Maven Clinic, the world's largest virtual clinic for women's and family health, today announced the appointment of Dr. Rachel Hardeman, a nationally recognized reproductive health equity researcher, as Maven's newest Visiting Scientist. As part of its commitment to driving equitable health outcomes for women and families, Maven also announced that it has established a Community Advisory Board and formalized a Culturally and Linguistically Appropriate Services (CLAS) program aligned to the Department of Health and Human Services (HHS) standards for health equity.

Key Points: 
  • NEW YORK, March 27, 2024 /PRNewswire/ -- Maven Clinic , the world's largest virtual clinic for women's and family health, today announced the appointment of Dr. Rachel Hardeman, a nationally recognized reproductive health equity researcher, as Maven's newest Visiting Scientist.
  • Her findings have appeared in publications such as the New England Journal of Medicine and the American Journal of Public Health.
  • She currently serves as the first ever Blue Cross Endowed Professor of Health and Racial Equity at the University of Minnesota.
  • It also includes commitments to workforce development, ensuring that 100% of Maven front-line staff receive comprehensive training in health equity.

Trupanion, leading pet medical insurance provider, teams up with renowned animal health experts to raise awareness around pet behavioral health

Retrieved on: 
Thursday, December 7, 2023

The timing of this Trupanion-hosted event coincides with rising veterinary visits related to behavioral concerns in pets.

Key Points: 
  • The timing of this Trupanion-hosted event coincides with rising veterinary visits related to behavioral concerns in pets.
  • During the live event, pet parents received invaluable guidance on enhancing their pets' well-being by understanding and addressing behavioral issues.
  • Here, we share five key takeaways from the event to help pet parents better manage the behavioral health of their beloved furry companions:
    Recognize your pet's normal behavior.
  • Trupanion's Chief Veterinary Officer, Dr. Steve Weinrauch and our panel of animal health experts, are available to share related insights and tips into managing pet behavioral health.

Supporting Your Pet's Behavioral Health During the Back-to-Office Transition: Join Trupanion's YouTube Premiere for Expert Guidance

Retrieved on: 
Monday, November 20, 2023

SEATTLE, Nov. 20, 2023 (GLOBE NEWSWIRE) -- As pet parents settle into the school run, work-week routine, Trupanion, the leading insurance provider for cats and dogs, is raising awareness around pet behavioral health, and the potential impact of these transitions on our pets and ourselves.

Key Points: 
  • On December 6, 2023, Trupanion will be hosting a YouTube Premiere, “Understanding & Managing Behavioral Health in Pets”.
  • Throughout the Premiere, panelists will discuss topics pertaining to pet behavioral health and offer expert guidance on how to manage behavioral health issues in our pets.
  • This Premiere comes at a time of rising veterinary visits related to behavioral concerns in pets.
  • In addition to offering guidance to pet owners, the expert panelists will discuss pet behavioral health, including how to recognize behavioral health issues and behavioral, medicinal and therapeutic treatment considerations.

Syra Health to Expand its Innovative Solutions to Federal Government Agencies

Retrieved on: 
Thursday, December 7, 2023

CARMEL, Ind., Dec. 7, 2023 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare company addressing some of healthcare's most significant challenges by providing innovative services and technology solutions, today announced that it is expanding its reach beyond state and local government agencies to now include supplying its products, services, and solutions to the federal government.

Key Points: 
  • CARMEL, Ind., Dec. 7, 2023 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare company addressing some of healthcare's most significant challenges by providing innovative services and technology solutions, today announced that it is expanding its reach beyond state and local government agencies to now include supplying its products, services, and solutions to the federal government.
  • "Expanding our business at the federal level is a natural next step for Syra Health," said Dr. Deepika Vuppalanchi, CEO, Syra Health.
  • Syra Health currently has 13 active contracts across 12 states nationwide, supplying state and local governments with clinical staffing, mental and behavioral health solutions, and population health services.
  • "We have a strong foundation of health and medical services, solutions, and clinical staffing that allow us to expand into the federal market," said Sandeep Allam, Executive Chairman and President, Syra Health.

Syra Health Secures Two-Year Contract to Assess and Implement Culturally and Linguistically Appropriate Services for Minnesota Department of Human Services

Retrieved on: 
Tuesday, November 7, 2023

CARMEL, Ind., Nov. 7, 2023 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare company addressing some of healthcare's most significant challenges in behavioral and mental health, digital health, and population health today announced the receipt of a two-year contract to assess the needs of the Hispanic and Latino communities in Hennepin County, Minnesota and to implement Culturally and Linguistically Appropriate Services (CLAS) standards in support of those needs.

Key Points: 
  • Developed by the U.S. Department of Health and Human Services' (HHS) Office of Minority Health, the National CLAS standards are a set of 15 action steps for implementing culturally and linguistically appropriate services.
  • According to HHS, "CLAS standards are intended to advance health equity, improve quality, and help eliminate healthcare disparities."
  • Syra Health is partnering with a Federally Qualified Health Center – People's Center Clinics and Services in Hennepin County to perform mixed methods research, identify baseline measurements, and to help the clinic implement CLAS standards.
  • "We are enthusiastic about the opportunity this CLAS contract presents," said Dr. Srikant Devaraj, Vice President of Data Analytics, Syra Health.

ClassLink Unveils Learning Analytics Updates to Help Schools Make Data-Driven Decisions at CLAS 2023

Retrieved on: 
Tuesday, October 10, 2023

ClassLink shared the announcements during the third annual ClassLink Learning Analytics Summit (CLAS) held on October 4 and 5, 2023.

Key Points: 
  • ClassLink shared the announcements during the third annual ClassLink Learning Analytics Summit (CLAS) held on October 4 and 5, 2023.
  • Visit ClassLink Academy to learn more.‍
    Explore the new Learning Analytics Community within the ClassLink Community.
  • Join this group to connect with fellow ClassLink customers already leveraging ClassLink Analytics to make informed decisions about digital learning.
  • - Mary Batiwalla, Director of Evaluation Analytics, ClassLink
    ‍Visit classlink.com/learning-analytics to request a demo and learn more about how you can make informed digital learning decisions with ClassLink Analytics.

URAC offers new health equity accreditation for a wide-range of health care organizations

Retrieved on: 
Wednesday, October 4, 2023

WASHINGTON, Oct. 4, 2023 /PRNewswire/ -- URAC, the nation's largest independent health care accreditation organization, today launched a health equity program that will showcase organizations' commitment to health equity and addressing health care disparities within the communities they serve. This accreditation, created in collaboration with the National Minority Quality Forum (NMQF) and a highly diverse panel of experts, is broadly applicable to any organization providing health care services.

Key Points: 
  • In collaboration with the National Minority Quality Forum, URAC developed an expert-informed accreditation
    WASHINGTON, Oct. 4, 2023 /PRNewswire/ -- URAC, the nation's largest independent health care accreditation organization, today launched a health equity program that will showcase organizations' commitment to health equity and addressing health care disparities within the communities they serve.
  • As health equity continues to evolve, we must transform the lens through which organizations evaluate and commit to health equity principles.
  • Organizations who seek URAC's health equity accreditation can demonstrate commitment to driving equitable access to optimal health for all members of the population they serve and consistently improving health care quality and outcomes.
  • This accreditation is based on health equity standards, acknowledging that health outcomes are shaped both within and beyond health care by elements such as social and economic circumstances, environment, health behaviors, genetics and health care access.

Class Acceleration Corp. Files Proxy to Extend the Date to Consummate a Business Combination

Retrieved on: 
Thursday, December 15, 2022

Class Acceleration Corp.’s Board of Directors asks shareholders to vote FOR proposal 1 prior to the Company’s 2022 meeting of stockholders on December 20, 2022.

Key Points: 
  • Class Acceleration Corp.’s Board of Directors asks shareholders to vote FOR proposal 1 prior to the Company’s 2022 meeting of stockholders on December 20, 2022.
  • Michael Moe, Class Acceleration Corp.’s Chief Executive Officer stated, “There are immediate and actionable opportunities in progress that will allow Class to complete a business combination.
  • Given the time of the year and volatility in the capital markets, additional time is required to complete a business combination, and we are asking shareholders to vote for proposal 1.
  • The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

CLAS is Back in Session! ClassLink Learning Analytics Summit Returns October 2022

Retrieved on: 
Tuesday, July 12, 2022

CLIFTON, N.J., July 12, 2022 /PRNewswire/ --ClassLink announced this week that their 2nd annual virtual ClassLink Learning Analytics Summit (CLAS) will be held on October 6 and 7, 2022, from 1:00 PM ET4:00 PM ET each day.

Key Points: 
  • CLIFTON, N.J., July 12, 2022 /PRNewswire/ --ClassLink announced this week that their 2nd annual virtual ClassLink Learning Analytics Summit (CLAS) will be held on October 6 and 7, 2022, from 1:00 PM ET4:00 PM ET each day.
  • CLAS helps school leaders learn to translate data into easy-to-understand narratives that drive action around equity, instruction, and professional development.
  • Through practical and interactive sessions with analytics experts, education leaders, and ClassLink senior leadershipattendees will learn to become data storytellers.
  • ClassLink is a global education provider of access and analytics products that create more time for learning and help schools better understand digital engagement.

Claritas Announces Approval from OTC to Up-List to OTCQB

Retrieved on: 
Thursday, April 7, 2022

SAN FRANCISCO, CA and TORONTO, ON, April 07, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE: CLAS and OTC: CLAZF) (the "Company" or "Claritas") is pleased to announce that it has obtained approval from the OTC Markets Group for listing of its Common Shares on the OTCQB.

Key Points: 
  • SAN FRANCISCO, CA and TORONTO, ON, April 07, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE: CLAS and OTC: CLAZF) (the "Company" or "Claritas") is pleased to announce that it has obtained approval from the OTC Markets Group for listing of its Common Shares on the OTCQB.
  • We undertook the stringent qualification process for the OTCQB listing because we believe that trading on the OTCQB tier will bring added value to our shareholders.
  • Claritas Pharmaceuticals, Inc. ("Claritas") is committed to developing new treatments for a variety of diseases and disorders, by discovering, developing, manufacturing, and delivering innovative human therapeutics.
  • Claritas focuses on areas of unmet medical need and leverages its expertise to find solutions that will improve health outcomes and dramatically improve people's lives.